Drug · DIN 02027089
FLUORESCEIN
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since July 10, 2018; first marketed December 31, 1994.
- Drug Identification Number (DIN)
- 02027089
- Company (DIN owner)
- Pharma Stulln Inc.Pointe-Claire, Quebec, Canada
- Schedule
- Ethical
- Dosage form
- Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Other diagnostic agents V04CX
- Class
- Human
- Record last updated
- April 24, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| FLUORESCEIN SODIUM | 100 MG | ML |
Other DINs named FLUORESCEIN
- DIN 02027097 · Cancelled Post Market